close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ANIP

Recent news which mentions ANIP

< Previous 1 2 3 Next >
ANI Pharmaceuticals's Earnings Outlook
Tickers ANIP
Tags ANIP Benzinga Market News
From Benzinga
Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know
Tickers ANIP
Tags BZI/AAR/UPDATE Analyst Ratings Benzinga
From Benzinga
Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?
Tickers ANIP
Tags General News Trading Ideas
From Benzinga
Expert Ratings for ANI Pharmaceuticals
Tickers ANIP
Tags Market News ANIP Benzinga
From Benzinga
Analyst Expectations for ANI Pharmaceuticals's Future
Tickers ANIP
Tags Market News Benzinga ANIP
From Benzinga
What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals
Tickers ANIP
Tags BZI/AAR Market News Benzinga
From Benzinga
7 A-Rated Biotech Stocks for Your August Buy List
Tickers ANIP ELVN IMGN LLY
Tags ANIP LLY IMGN
From InvestorPlace
Where ANI Pharmaceuticals Stands With Analysts
Tickers ANIP
Tags BZI/AAR Benzinga ANIP
From Benzinga
Looking Into ANI Pharmaceuticals's Return On Capital Employed
Tickers ANIP
Tags Benzinga ANIP Market News
From Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Tickers ANIP APM BAK BAOS
Tags NBTX SIX INOD
From Benzinga
Why ANI Pharmaceuticals Stock Is Soaring Today
Tickers ANIP
Tags Benzinga why it's moving Guidance
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tickers ADTX ANIP APM BLCM
Tags Benzinga BZI/TFM IMRN
From Benzinga
Earnings Preview For ANI Pharmaceuticals
Tickers ANIP
Tags BZI/EP Benzinga ANIP
From Benzinga
ANI Pharmaceuticals Earnings Perspective: Return On Capital Employed
Tickers ANIP
Tags BZI/ROCE Earnings Market News
From Benzinga
Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch
Tickers ANIP MNK
Tags Analyst Ratings Health Care Movers
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Tickers ABBV AMBA AMRC ANIP
Tags FA BTE NTES
From Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview
Tickers ANIP
Tags Benzinga ANIP Market News
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers AIRS ALZN ANIP APTX
Tags BNR LHDX ANIP
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Tickers ACCD ALVO AMP AMWL
Tags KC PATH Analyst Ratings
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Tickers AMPH ANIP AZN BEAT
Tags ANIP AZN Biotech Catalysts / EOD Summary
From Benzinga
The Food and Drug Administration has approved Dexamethasone Tablets USP by ANI Pharma (ANIP)
Tickers ANIP
Tags Analyst Rating ANIP News
From Best Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers ALBO ANIP AYLA CEMI
Tags ONVO CEMI TTOO
From Benzinga
ANI Pharmaceuticals: Q2 Earnings Insights
Tickers ANIP
Tags Earnings ANIP Benzinga
From Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview
Tickers ANIP
Tags Benzinga ANIP Market News
From Benzinga
ANI Pharmaceuticals: Q1 Earnings Insights
Tickers ANIP
Tags News BZI/Recaps Market News
From Benzinga
ANI Pharmaceuticals Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET
Tickers ANIP
Tags News Market News BZI/CONF
From Benzinga
Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC)
Tickers ABNB AMC ANIP CANO
Tags Market News CRWD Small Cap
From Benzinga
ANI Pharmaceuticals's Return On Capital Employed Insights
Tickers ANIP
Tags BZI/ROCE Earnings Market News
From Benzinga
68 Biggest Movers From Yesterday
Tickers AGFY AHPI ANIP ASLE
Tags TUSK IO HOLI
From Benzinga
Mid-Afternoon Market Update: Nasdaq Rises Over 200 Points; ANI Pharmaceuticals Shares Slide
Tickers ANIP BTTX CANO EDU
Tags Benzinga Earnings Mid/Afternoon Market Update
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today